Abstract

The long-term performance of SAPIEN® transcatheter aortic valve replacement (TAVR) is not known. Therefore, we examined the hemodynamic profile of SAPIEN® TAVR over 5 years of follow-up and compared these results with surgical bioprosthetic aortic valve replacement (SAVR). All patients receiving

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call